6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Oorspronkelijke tekst

Deze vertaling beoordelen

Je feedback wordt gebruikt om Google Translate te verbeteren

Latest Press Releases

Time	Headline
Just now	Helio Nears the Completion of Its Debt Restructuring Program
Just now	Chicago Atlantic BDC, Inc. Announces Date for First Quarter 2026 Results Release and Conference Call
Just now	BREZTRI approved in the US for asthma as first and only triple therapy for patients 12 years of age and older
Just now	Climb Bio, Inc. Announces $110.0 Million Private Placement
1m ago	Rocket Pharmaceuticals Announces $180 Million Sale of Priority Review Voucher

About

Immucell Corporation (NASDAQ:ICCC) — investor relations, events, news, and company updates on 6ix.

Latest News

ImmuCell Bolsters its Innovation Strategy with Appointments of Dr. Gilles Guillemette and Dr. Anthony DiMarco to the Board, and Moves to a Smaller Board of Independent Directors

ImmuCell Announces a 28.4% Increase in Product Sales in Q1 of 2026, based on Preliminary, Unaudited Sales Results

ImmuCell Appoints Former Elanco Animal Health Board Member Kathy Turner to Board

ImmuCell Announces Unaudited Financial Results for the Year Ended December 31, 2025

ImmuCell to Announce Unaudited Financial Results for the Quarter and Year Ended December 31, 2025

Financials

Revenue

$27.64 M

Market Cap

$58.26 M

EPS

-0.12

Community Chat

Ask AI